Clinical Trials Browser

Phase 2 × INDUSTRY × satraplatin × Clear all

NCT00370383 2012-08-07

A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00268970 2012-04-30

Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00265655 2012-03-28

Satraplatin for Patients With Metastatic Breast Cancer (MBC)

Phase 2 Completed

Breast Neoplasms